Current position
Education
- 2024: PhD in Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University
- 2019: Doctor of Pharmacy degree in Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University
- 2018: Master's degree in Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University
Teaching activities
Experience abroad
- Utrecht University, Faculty of Science, Division of Pharmacoepidemiology & Clinical Pharmacology
- Utrecht Summer School in Pharmacoepidemiology and Drug Safety (4 – 8 July 2022)
- 5-month ERASMUS+ traineeship (May–Sep 2022)
- supervisor: Dr. Daniala L. Weir
- Sorbonne University, Faculty of Medicine (4EU+ Alliance)
- integrated 4EU+ Pharmacoepidemiology educational course (March–April 2022)
Professional membership
- European Society of Clinical Pharmacy (ESCP)
- Czech Pharmaceutical Society – Section of Clinical Pharmacy
- Czech Chamber of Pharmacists
Grant projects
- EU COST Action
- Proposal OC-2024-1-27981: The Medication Safety Network (MedSafetyNet)
- team member: secondary proposer
- status: awaiting decision (5/2025)
- OP JAK (Johannes Amos Comenius Programme)
- project BIPOLE - WP6: Personalized Pharmacotherapy
- team member: junior researcher
- 7/2024–6/2028
- Canadian Institutes of Health Research (CIHR)
- networking event: Individual Patient Data Meta-Analysis on Adverse Drug Events Across the Continuum of Care
- travel grant for a networking event at Utrecht University in 2025
- Charles University Grant Agency
Publications
PubMed list
Očovská Z, Procházková J, Maříková M, Vlček J. Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: A cross-sectional study. Expert Opin Drug Saf. 2024; 23(4):457-467. doi: 10.1080/14740338.2023.2295980
Očovská Z, Maříková M, Vlček J. Potentially Clinically Significant Drug-Drug Interactions in Older Patients Admitted to the Hospital: A Cross-sectional Study. Front Pharmacol. 2023;14:1088900. doi: 10.3389/fphar.2023.1088900
Očovská Z, Maříková M, Kočí J, Vlček J. Drug-related Hospital Admissions via the Department of Emergency Medicine: A Cross-sectional Study from the Czech Republic. Front Pharmacol. 2022; 13: 899151. doi: 10.3389/fphar.2022.899151
Maříková M, Očovská Z, Nerad V, Kuběna AA, Blaha V, Vlček J. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic. Int J Clin Pharm. 2021;43(5):1218-1226. doi: 10.1007/s11096-021-01237-y
International collaboration
- Dr. Daniala L. Weir (Utrecht University)
- Dr. Fatma Karapinar (Maastricht University)
Research interests
- Pharmacoepidemiology:
- epidemiologic characteristics of adverse drug events that lead to hospitalization
- the potential of using routinely collected data to detect adverse drug events that lead to hospitalization
- Drug Safety and Pharmacovigilance:
- causality assessment of adverse drug reactions identified in post-marketing period
- proposing strategies to detect adverse drug reactions that result in hospitalizations
- Drug Information:
- comparison of drug-information sources to detect and address various drug-related problems (e.g. drug-drug interactions, drug dosing in renal impairment)
- Health services and outcomes research
- identification and risk minimization of drug-related problems